Antidepressant potential of metabotropic glutamate receptor mGlu and mGlu negative allosteric modulators.
作者信息
Joffe Max E, Conn P Jeffrey
机构信息
Department of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.
Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA.
出版信息
Neuropsychopharmacology. 2019 Jan;44(1):214-236. doi: 10.1038/s41386-018-0192-8.
Abstract
摘要
相似文献
1
Antidepressant potential of metabotropic glutamate receptor mGlu and mGlu negative allosteric modulators.代谢型谷氨酸受体mGlu和mGlu负变构调节剂的抗抑郁潜力
Neuropsychopharmacology. 2019 Jan;44(1):214-236. doi: 10.1038/s41386-018-0192-8.
2
mGlu and mGlu Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects.代谢型谷氨酸受体和代谢型谷氨酸受体负变构调节剂可差异化增强丘脑皮质传递并发挥快速抗抑郁样作用。
Neuron. 2020 Jan 8;105(1):46-59.e3. doi: 10.1016/j.neuron.2019.09.044. Epub 2019 Nov 14.
3
Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease.代谢型谷氨酸受体：神经系统疾病的突触调节剂和治疗靶点。
Neurology. 2008 Mar 18;70(12):964-8. doi: 10.1212/01.wnl.0000306315.03021.2a.
4
Are compounds acting at metabotropic glutamate receptors the answer to treating depression?作用于代谢型谷氨酸受体的化合物是治疗抑郁症的答案吗？
Expert Opin Investig Drugs. 2006 Dec;15(12):1545-53. doi: 10.1517/13543784.15.12.1545.
5
Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.代谢型谷氨酸受体2正变构调节剂的药理学和分子特征重印版
Neuropharmacology. 2017 Mar 15;115:115-127. doi: 10.1016/j.neuropharm.2016.08.040. Epub 2017 Feb 16.
6
Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.代谢型谷氨酸受体2正变构调节剂的药理学和分子特征
Neuropharmacology. 2016 Dec;111:253-265. doi: 10.1016/j.neuropharm.2016.08.032. Epub 2016 Aug 30.
7
Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.脑源性神经营养因子/TrkB 信号在 II 型代谢型谷氨酸受体拮抗剂抗抑郁作用中的作用：动物模型研究。
Behav Brain Res. 2013 Feb 1;238:48-52. doi: 10.1016/j.bbr.2012.10.023. Epub 2012 Oct 23.
8
Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.重性抑郁障碍中的认知障碍及 mGlu2 受体作为治疗靶点。
Neuropharmacology. 2013 Jan;64:337-46. doi: 10.1016/j.neuropharm.2012.08.001. Epub 2012 Aug 23.
9
Recent patents on positive allosteric modulators of the metabotropic glutamate 5 receptor as a potential treatment for schizophrenia.代谢型谷氨酸受体5正向变构调节剂作为精神分裂症潜在治疗方法的近期专利。
Recent Pat CNS Drug Discov. 2010 Jan;5(1):23-34. doi: 10.2174/157488910789753512.
10
Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression.在抑郁症啮齿动物模型中对一种代谢型谷氨酸受体2/3负性变构调节剂的表征。
J Neurogenet. 2011 Dec;25(4):152-66. doi: 10.3109/01677063.2011.627485.
引用本文的文献
1
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.变构调节代谢型谷氨酸受体作为神经精神疾病治疗的新策略。
Pharmacol Rev. 2022 Jul;74(3):630-661. doi: 10.1124/pharmrev.121.000540.
2
Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.探索 II 型代谢型谷氨酸受体在雷特综合征和 MECP2 重复综合征小鼠模型中的调节作用。
Neuropharmacology. 2022 May 15;209:109022. doi: 10.1016/j.neuropharm.2022.109022. Epub 2022 Mar 3.
3
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders.压力突触 2.0：应激相关神经精神障碍的病理生理机制。
Nat Rev Neurosci. 2022 Feb;23(2):86-103. doi: 10.1038/s41583-021-00540-x. Epub 2021 Dec 10.
4
Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents.评价新型变构 mGlu2/3 受体拮抗剂 TP0178894 前药 TP0473292（TS-161）在健康受试者中的安全性、耐受性和药代动力学特征及其在啮齿动物中的抗抑郁样作用。
Int J Neuropsychopharmacol. 2022 Feb 11;25(2):106-117. doi: 10.1093/ijnp/pyab062.
5
mGlu and mGlu Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects.代谢型谷氨酸受体和代谢型谷氨酸受体负变构调节剂可差异化增强丘脑皮质传递并发挥快速抗抑郁样作用。
Neuron. 2020 Jan 8;105(1):46-59.e3. doi: 10.1016/j.neuron.2019.09.044. Epub 2019 Nov 14.
6
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.快速作用抗抑郁药的神经生物学：对 GluA1 突触功能的趋同效应。
Mol Psychiatry. 2019 Dec;24(12):1816-1832. doi: 10.1038/s41380-019-0400-x. Epub 2019 Mar 20.
7
()-hydroxynorketamine exerts mGlu receptor-dependent antidepressant actions.()-羟基去甲氯胺通过 mGlu 受体发挥抗抑郁作用。
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6441-6450. doi: 10.1073/pnas.1819540116. Epub 2019 Mar 13.
8
Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.从 mGlu 受体的变构调节中获得神经药理学的新见解。
Trends Pharmacol Sci. 2019 Apr;40(4):240-252. doi: 10.1016/j.tips.2019.02.006. Epub 2019 Feb 26.
Zotero 插件